Selected research
Industry Growth & Trends
Global Crizotinib Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Crizotinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Crizotinib Drugs include Wanbang Biopharmaceuticals, Pfizer, Genvio Pharma, Everest Pharmaceuticals, Drug International, Beacom and Azista, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Crizotinib Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Crizotinib Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crizotinib Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Crizotinib Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Crizotinib Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Crizotinib Drugs Market by Company
Wanbang Biopharmaceuticals
Pfizer
Genvio Pharma
Everest Pharmaceuticals
Drug International
Beacom
Azista
Crizotinib Drugs Segment by Type
Capsules
Oral Pellets
Crizotinib Drugs Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Crizotinib Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crizotinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crizotinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crizotinib Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crizotinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Crizotinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Oral Pellets
Applications
- Hospital and Clinic
- Retail Pharmacies
- Other
Companies covered
- Wanbang Biopharmaceuticals
- Pfizer
- Genvio Pharma
- Everest Pharmaceuticals
- Drug International
- Beacom
- Azista
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Crizotinib Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Crizotinib Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Crizotinib Drugs Market by Type
- 1.3.1 Capsules
- 1.3.2 Oral Pellets
- 1.4 Global Crizotinib Drugs Market Size by Type
- 1.4.1 Global Crizotinib Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Crizotinib Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Crizotinib Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Crizotinib Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Crizotinib Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Crizotinib Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Crizotinib Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Crizotinib Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Crizotinib Drugs Industry Trends
- 2.2 Crizotinib Drugs Industry Drivers
- 2.3 Crizotinib Drugs Industry Opportunities and Challenges
- 2.4 Crizotinib Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Crizotinib Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Crizotinib Drugs Sales (2021-2026)
- 3.3 Global Top Players by Crizotinib Drugs Price (2021-2026)
- 3.4 Global Crizotinib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Crizotinib Drugs Major Company Production Sites & Headquarters
- 3.6 Global Crizotinib Drugs Company, Product Type & Application
- 3.7 Global Crizotinib Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Crizotinib Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Crizotinib Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Crizotinib Drugs Tier 1, Tier 2, and Tier 3
4 Crizotinib Drugs Regional Status and Outlook
- 4.1 Global Crizotinib Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Crizotinib Drugs Historic Market Size by Region
- 4.2.1 Global Crizotinib Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Crizotinib Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Crizotinib Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Crizotinib Drugs Forecasted Market Size by Region
- 4.3.1 Global Crizotinib Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Crizotinib Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Crizotinib Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Crizotinib Drugs by Application
- 5.1 Crizotinib Drugs Market by Application
- 5.1.1 Hospital and Clinic
- 5.1.2 Retail Pharmacies
- 5.1.3 Other
- 5.2 Global Crizotinib Drugs Market Size by Application
- 5.2.1 Global Crizotinib Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Crizotinib Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Crizotinib Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Crizotinib Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Crizotinib Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Crizotinib Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Crizotinib Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Crizotinib Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Wanbang Biopharmaceuticals
- 6.1.1 Wanbang Biopharmaceuticals Company Information
- 6.1.2 Wanbang Biopharmaceuticals Business Overview
- 6.1.3 Wanbang Biopharmaceuticals Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Wanbang Biopharmaceuticals Crizotinib Drugs Product Portfolio
- 6.1.5 Wanbang Biopharmaceuticals Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Pfizer Crizotinib Drugs Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Genvio Pharma
- 6.3.1 Genvio Pharma Company Information
- 6.3.2 Genvio Pharma Business Overview
- 6.3.3 Genvio Pharma Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Genvio Pharma Crizotinib Drugs Product Portfolio
- 6.3.5 Genvio Pharma Recent Developments
- 6.4 Everest Pharmaceuticals
- 6.4.1 Everest Pharmaceuticals Company Information
- 6.4.2 Everest Pharmaceuticals Business Overview
- 6.4.3 Everest Pharmaceuticals Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Everest Pharmaceuticals Crizotinib Drugs Product Portfolio
- 6.4.5 Everest Pharmaceuticals Recent Developments
- 6.5 Drug International
- 6.5.1 Drug International Company Information
- 6.5.2 Drug International Business Overview
- 6.5.3 Drug International Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Drug International Crizotinib Drugs Product Portfolio
- 6.5.5 Drug International Recent Developments
- 6.6 Beacom
- 6.6.1 Beacom Company Information
- 6.6.2 Beacom Business Overview
- 6.6.3 Beacom Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Beacom Crizotinib Drugs Product Portfolio
- 6.6.5 Beacom Recent Developments
- 6.7 Azista
- 6.7.1 Azista Company Information
- 6.7.2 Azista Business Overview
- 6.7.3 Azista Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Azista Crizotinib Drugs Product Portfolio
- 6.7.5 Azista Recent Developments
7 North America by Country
- 7.1 North America Crizotinib Drugs Sales by Country
- 7.1.1 North America Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Crizotinib Drugs Sales by Country (2021-2026)
- 7.1.3 North America Crizotinib Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Crizotinib Drugs Market Size by Country
- 7.2.1 North America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Crizotinib Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Crizotinib Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Crizotinib Drugs Sales by Country
- 8.1.1 Europe Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Crizotinib Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Crizotinib Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Crizotinib Drugs Market Size by Country
- 8.2.1 Europe Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Crizotinib Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Crizotinib Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Crizotinib Drugs Sales by Country
- 9.1.1 Asia-Pacific Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Crizotinib Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Crizotinib Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Crizotinib Drugs Market Size by Country
- 9.2.1 Asia-Pacific Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Crizotinib Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Crizotinib Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Crizotinib Drugs Sales by Country
- 10.1.1 South America Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Crizotinib Drugs Sales by Country (2021-2026)
- 10.1.3 South America Crizotinib Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Crizotinib Drugs Market Size by Country
- 10.2.1 South America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Crizotinib Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Crizotinib Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Crizotinib Drugs Sales by Country
- 11.1.1 Middle East and Africa Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Crizotinib Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Crizotinib Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Crizotinib Drugs Market Size by Country
- 11.2.1 Middle East and Africa Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Crizotinib Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Crizotinib Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Crizotinib Drugs Value Chain Analysis
- 12.1.1 Crizotinib Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Crizotinib Drugs Production Mode & Process
- 12.2 Crizotinib Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Crizotinib Drugs Distributors
- 12.2.3 Crizotinib Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst